These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8826099)

  • 61. Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.
    Kipp W; Bamhuhiiga J; Rubaale T; Büttner DW
    Am J Trop Med Hyg; 2003 Dec; 69(6):621-3. PubMed ID: 14740878
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ivermectin improves the skin condition and self-esteem of females with onchocerciasis: a report of two cases.
    Amazigo UV; Nnoruka E; Maduka C; Bump J; Benton B; Sékétéli A
    Ann Trop Med Parasitol; 2004 Jul; 98(5):533-7. PubMed ID: 15257804
    [No Abstract]   [Full Text] [Related]  

  • 63. The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin.
    Duke BO; Zea-Flores G; Muñoz B
    Trop Med Parasitol; 1991 Sep; 42(3):175-80. PubMed ID: 1801140
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ivermectin effect on microfilariae of Onchocerca volvulus after a single oral dose in humans.
    Soboslay PT; Newland HS; White AT; Erttmann KD; Albiez EJ; Taylor HR; Williams PN; Greene BM
    Trop Med Parasitol; 1987 Mar; 38(1):8-10. PubMed ID: 3602843
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Onchocerciasis in Yemen: Time to take action against a neglected tropical parasitic disease.
    Abdul-Ghani R; Mahdy MAK; Beier JC
    Acta Trop; 2016 Oct; 162():133-141. PubMed ID: 27325293
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cutaneous onchocercoma.
    Okulicz JF; Stibich AS; Elston DM; Schwartz RA
    Int J Dermatol; 2004 Mar; 43(3):170-2. PubMed ID: 15009384
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis.
    White AT; Newland HS; Taylor HR; Erttmann KD; Keyvan-Larijani E; Nara A; Aziz MA; D'Anna SA; Williams PN; Greene BM
    J Infect Dis; 1987 Sep; 156(3):463-70. PubMed ID: 3302053
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sowda--onchocerciasis in north Yemen: a clinicopathologic study of 18 patients.
    Connor DH; Gibson DW; Neafie RC; Merighi B; Buck AA
    Am J Trop Med Hyg; 1983 Jan; 32(1):123-37. PubMed ID: 6824118
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of reactive onchocercal skin lesions during a placebo-controlled trial with ivermectin among persons without lesions at baseline.
    Brieger WR; Kale OO; Ososanya OO
    Trop Doct; 2001 Apr; 31(2):96-8. PubMed ID: 11321284
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adverse reactions after community treatment of onchocerciasis with ivermectin in Guatemala.
    Zea-Flores R; Richards FO; González-Peralta C; Castro Ramirez J; Zea-Flores G; Collins RC; Cupp E
    Trans R Soc Trop Med Hyg; 1992; 86(6):663-6. PubMed ID: 1287939
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Onchodermal skin disease in a hyperendemic onchocerciasis focus in western Uganda.
    Kipp W; Bamhuhiiga J
    Am J Trop Med Hyg; 2002 Nov; 67(5):475-9. PubMed ID: 12479547
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Occurrence and diagnosis of Mansonella streptocerca in Uganda.
    Fischer P; Bamuhiiga J; Büttner DW
    Acta Trop; 1997 Jan; 63(1):43-55. PubMed ID: 9083584
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of renal function in onchocerciasis patients before and after therapy.
    Burchard GD; Kubica T; Tischendorf FW; Kruppa T; Brattig NW
    Am J Trop Med Hyg; 1999 Jun; 60(6):980-6. PubMed ID: 10403331
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low levels of transforming growth factor-beta (TGF-beta) and reduced suppression of Th2-mediated inflammation in hyperreactive human onchocerciasis.
    Korten S; Hoerauf A; Kaifi JT; Büttner DW
    Parasitology; 2011 Jan; 138(1):35-45. PubMed ID: 20619070
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Onchocerciasis (river blindness).
    Borup LH; Peters JS; Sartori CR
    Cutis; 2003 Oct; 72(4):297-302; quiz 296. PubMed ID: 14604081
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Side-effects of ivermectin in treatment of onchocerciasis.
    Rothova A; van der Lelij A; Stilma JS; Wilson WR; Barbe RF
    Lancet; 1989 Jun; 1(8652):1439-41. PubMed ID: 2567440
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adverse events following mass ivermectin therapy for onchocerciasis.
    Chijioke CP; Okonkwo PO
    Trans R Soc Trop Med Hyg; 1992; 86(3):284-6. PubMed ID: 1412654
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ultrasonographical investigations of onchocerciasis in Liberia.
    Leichsenring M; Tröger J; Nelle M; Büttner DW; Darge K; Doehring-Schwerdtfeger E
    Am J Trop Med Hyg; 1990 Oct; 43(4):380-5. PubMed ID: 2240365
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection.
    Bakajika D; Kanza EM; Opoku NO; Howard HM; Mambandu GL; Nyathirombo A; Nigo MM; Kennedy KK; Masembe SL; Mumbere M; Kataliko K; Bolay KM; Attah SK; Olipoh G; Asare S; Vaillant M; Halleux CM; Kuesel AC
    PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010079. PubMed ID: 35476631
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cutaneous onchocerciasis.
    Maso MJ; Kapila R; Schwartz RA; Wiltz H; Kaminski ZC; Lambert WC
    Int J Dermatol; 1987 Nov; 26(9):593-6. PubMed ID: 3443529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.